Fruttero R - Search Results

1

Inhibition of human placenta glutathione transferase P1-1 by the antibiotic calvatic acid and its diazocyanide analogue--evidence for multiple catalytic intermediates.

Antonini G, Pitari G, Caccuri AM, Ricci G, Boschi D, Fruttero R, Gasco A, Ascenzi P. Antonini G, et al. Among authors: fruttero r. Eur J Biochem. 1997 May 1;245(3):663-7. doi: 10.1111/j.1432-1033.1997.00663.x. Eur J Biochem. 1997. PMID: 9183003 Free article.

2

Inhibition of human placenta glutathione transferase P1-1 by calvatic acid.

Caccuri AM, Ricci G, Desideri A, Buffa M, Fruttero R, Gasco A, Ascenzi P. Caccuri AM, et al. Among authors: fruttero r. Biochem Mol Biol Int. 1994 Apr;32(5):819-29. Biochem Mol Biol Int. 1994. PMID: 8069231

3

Activity of calvatic acid and its analogs against Helicobacter pylori.

Boschi D, Cena C, Fruttero R, Brenciaglia MI, Scaltrito MM, Dubini F, Gasco A. Boschi D, et al. Among authors: fruttero r. Pharmazie. 2001 Aug;56(8):670-2. Pharmazie. 2001. PMID: 11534353 No abstract available.

4

6-Cyclohexylmethoxy-5-(cyano-NNO-azoxy)pyrimidine-4-amine: a new scaffold endowed with potent CDK2 inhibitory activity.

Boschi D, Tosco P, Chandra N, Chaurasia S, Fruttero R, Griffin R, Wang LZ, Gasco A. Boschi D, et al. Among authors: fruttero r. Eur J Med Chem. 2013 Oct;68:333-8. doi: 10.1016/j.ejmech.2013.07.031. Epub 2013 Aug 11. Eur J Med Chem. 2013. PMID: 23994326

5

Alpha 1-adrenoceptor blocking activity of some ring-open analogues of prazosin.

Boschi D, Di Stilo A, Fruttero R, Medana C, Sorba G, Gasco A. Boschi D, et al. Among authors: fruttero r. Arch Pharm (Weinheim). 1994 Oct;327(10):661-7. doi: 10.1002/ardp.19943271012. Arch Pharm (Weinheim). 1994. PMID: 7826201

6

Identification of L-methionine oxidation products in tripeptides, in Met-enkephalin and in the bovine basic pancreatic trypsin inhibitor: 1H and 13C NMR study.

Fruttero R, Amiconi G, Ascoli F, Bolognesi M, Ascenzi P. Fruttero R, et al. Biochem Mol Biol Int. 1995 Apr;35(4):861-74. Biochem Mol Biol Int. 1995. PMID: 7542960

7

The furoxan system as a useful tool for balancing "hybrids" with mixed alpha 1-antagonist and NO-like vasodilator activities.

Fruttero R, Boschi D, Di Stilo A, Gasco A. Fruttero R, et al. J Med Chem. 1995 Dec 8;38(25):4944-9. doi: 10.1021/jm00025a012. J Med Chem. 1995. PMID: 8523408

8

Studies on agents with mixed NO-dependent vasodilating and beta-blocking activities.

Boschi D, Di Stilo A, Cena C, Lolli M, Fruttero R, Gasco A. Boschi D, et al. Among authors: fruttero r. Pharm Res. 1997 Dec;14(12):1750-8. doi: 10.1023/a:1012136030849. Pharm Res. 1997. PMID: 9453064

9

Studies on agents with mixed NO-dependent and calcium channel antagonistic vasodilating activities.

Cena C, Visentin S, Di Stilo A, Boschi D, Fruttero R, Gasco A. Cena C, et al. Among authors: fruttero r. Pharm Res. 2001 Feb;18(2):157-65. doi: 10.1023/a:1011072116210. Pharm Res. 2001. PMID: 11405285

10

Searching for balanced hybrid NO-donor 1,4-dihydropyridines with basic properties.

Boschi D, Caron G, Visentin S, Di Stilo A, Rolando B, Fruttero R, Gasco A. Boschi D, et al. Among authors: fruttero r. Pharm Res. 2001 Jul;18(7):987-91. doi: 10.1023/a:1010992412549. Pharm Res. 2001. PMID: 11496959

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

156 results

Search Page

Filters